These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Second-order NLO properties of bis-cyclometalated iridium(Ⅲ) complexes: Substituent effect and redox switch. Li X; Wang HQ; Ye JT; Zhang Y; Qiu YQ J Mol Graph Model; 2019 Jun; 89():131-138. PubMed ID: 30884450 [TBL] [Abstract][Full Text] [Related]
27. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019 [TBL] [Abstract][Full Text] [Related]
28. X-ray excitable luminescent polymer dots doped with an iridium(III) complex. Osakada Y; Pratx G; Hanson L; Solomon PE; Xing L; Cui B Chem Commun (Camb); 2013 May; 49(39):4319-21. PubMed ID: 23320256 [TBL] [Abstract][Full Text] [Related]
29. Iridium-catalyzed borylation of pyrene: irreversibility and the influence of ligand on selectivity. Ji L; Fucke K; Bose SK; Marder TB J Org Chem; 2015 Jan; 80(1):661-5. PubMed ID: 25459052 [TBL] [Abstract][Full Text] [Related]
30. Bay-Region Functionalisation of Ar-BIAN Ligands and Their Use Within Highly Absorptive Cationic Iridium(III) Dyes. Hasan K; Wang J; Pal AK; Hierlinger C; Guerchais V; Sen Soo H; García F; Zysman-Colman E Sci Rep; 2017 Nov; 7(1):15520. PubMed ID: 29138392 [TBL] [Abstract][Full Text] [Related]
31. Phosphorescent proteins for bio-imaging and site selective bio-conjugation of peptides and proteins with luminescent cyclometalated iridium(III) complexes. Shiu HY; Chong HC; Leung YC; Zou T; Che CM Chem Commun (Camb); 2014 Apr; 50(33):4375-8. PubMed ID: 24643302 [TBL] [Abstract][Full Text] [Related]
32. Iridium complex with antiangiogenic properties. Wilbuer A; Vlecken DH; Schmitz DJ; Kräling K; Harms K; Bagowski CP; Meggers E Angew Chem Int Ed Engl; 2010 May; 49(22):3839-42. PubMed ID: 20437440 [No Abstract] [Full Text] [Related]
33. Preparation of chiral-at-metal catalysts and their use in asymmetric photoredox chemistry. Ma J; Zhang X; Huang X; Luo S; Meggers E Nat Protoc; 2018 Apr; 13(4):605-632. PubMed ID: 29494576 [TBL] [Abstract][Full Text] [Related]
34. Substituent effect of ancillary ligands on the luminescence of bis[4,6-(di-fluorophenyl)-pyridinato-N,C2']iridium(III) complexes. Zhou Y; Li W; Liu Y; Zeng L; Su W; Zhou M Dalton Trans; 2012 Aug; 41(31):9373-81. PubMed ID: 22735268 [TBL] [Abstract][Full Text] [Related]
36. High electrochemiluminescence of a new water-soluble iridium(III) complex for determination of antibiotics. Li MJ; Jiao P; Lin M; He W; Chen GN; Chen X Analyst; 2011 Jan; 136(1):205-10. PubMed ID: 20944848 [TBL] [Abstract][Full Text] [Related]
37. A cationic iridium(III) complex showing aggregation-induced phosphorescent emission (AIPE) in the solid state: synthesis, characterization and properties. Shan GG; Zhang LY; Li HB; Wang S; Zhu DX; Li P; Wang CG; Su ZM; Liao Y Dalton Trans; 2012 Jan; 41(2):523-30. PubMed ID: 22042331 [TBL] [Abstract][Full Text] [Related]
38. A metal-based inhibitor of tumor necrosis factor-α. Leung CH; Zhong HJ; Yang H; Cheng Z; Chan DS; Ma VP; Abagyan R; Wong CY; Ma DL Angew Chem Int Ed Engl; 2012 Sep; 51(36):9010-4. PubMed ID: 22807261 [TBL] [Abstract][Full Text] [Related]
39. An investigation on the second order nonlinear optical response of tris-cyclometallated Ir(III) complexes with variously substituted 2-phenylpyridines. Zaarour M; Guerchais V; Le Bozec H; Dragonetti C; Righetto S; Roberto D; De Angelis F; Fantacci S; Lobello MG Dalton Trans; 2013 Jan; 42(1):155-9. PubMed ID: 23051730 [TBL] [Abstract][Full Text] [Related]